File, T., Goldberg, L., Paukner, S., Das, A., Gelone, S. P., Saviski, J., . . . Gasink, L. B. (2018). 2386. Efficacy of Lefamulin (LEF) vs. Moxifloxacin (MOX) Against Common Pathogens in Adults With Community-Acquired Bacterial Pneumonia (CABP): Results From the Phase 3 Lefamulin Evaluation Against Pneumonia (LEAP 1) Study. Open Forum Infect Dis.
Chicago Style citaatFile, Thomas, et al. "2386. Efficacy of Lefamulin (LEF) Vs. Moxifloxacin (MOX) Against Common Pathogens in Adults With Community-Acquired Bacterial Pneumonia (CABP): Results From the Phase 3 Lefamulin Evaluation Against Pneumonia (LEAP 1) Study." Open Forum Infect Dis 2018.
MLA citatieFile, Thomas, et al. "2386. Efficacy of Lefamulin (LEF) Vs. Moxifloxacin (MOX) Against Common Pathogens in Adults With Community-Acquired Bacterial Pneumonia (CABP): Results From the Phase 3 Lefamulin Evaluation Against Pneumonia (LEAP 1) Study." Open Forum Infect Dis 2018.